Diseases

Upsher-Smith Laboratories, LLC  declared that it sought U.S Food and Drug Administration's approval for new drug application (ANDA) for Bumetanide Tablets, USP, 0.5 mg, 1 mg, and 2 mg,…
Read More...

Industry leader in orthopaedic devices using advanced functional materials, MedShape declared successful performance of first surgeries using DynaNail XL TTC Fusion System.  The…
Read More...

Mallinckrodt plc affirmed enrolling first patient in the company's Phase 4, multi center, randomized, double-blind, placebo-controlled pilot study to facilitate evaluation of the…
Read More...

Takeda Pharmaceutical company Limited asserted that the U.S Food and Drug Administration has extended Fast Track designation to TAK-426 i.e Takeda's Zika virus vaccine candidate. …
Read More...

European Organisation for Research and Treatment of Cancer (EORTC) and Foundation Medicine collaborate to ascertain eligibility of patients for oncology clinical Trials of  Foundation…
Read More...

U.S Patent and Trademark Office permits a patent titled  “Method for Inducing an Immune Response and Formulations Thereof” for CEL-SCI Corporation's LEAPS Vaccine Platform technology.…
Read More...

U.S. Food and Drug Administration (FDA) has approved BioCardia's Investigational Device Exemption for the CardiAMP Chronic Myocardial Ischemia (CMI) Trial to treat patients with…
Read More...

U.S FDA has sanctioned CutisPharma's FIRVANQ (vancomycin hydrochloride) for oral solution, for the treatment of Clostridium difficile associated diarrhea and enterocolitis caused by …
Read More...

Theravance Biopharma and Mylan N.V confirmed U.S Food and Drug Administration's acceptance for reviewing the company's New Drug Application (NDA) for revefenacin (TD-4208), an…
Read More...

electroCore sought 510(k) clearance from the U.S Food and Drug Administration for an extended label for gammaCore (nVNS) as an acute treatment of pain associated with migraine in adult…
Read More...

Supplier of quality compounding products, supplies and equipment, Letco Medical along with ARL Bio Pharma collaborate to roll out their joint Quality Savings Program. The program…
Read More...

Global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, QT Vascular successfully…
Read More...

Clinical development Type C meeting with the US Food and Drug Administration (FDA) for its orally active anti-fibrotic lead drug candidate, PBI-4050 was declared by Prometic Life…
Read More...

Clinical-stage, biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, SillaJen declared the commencement of Phase 1/2 clinical trial of…
Read More...

In a bid to bring on board fresh participants for its weight loss surgery surgery thus making it accessible patients with  a considerably low BMI of 30-35, New Jersey Bariatric Center…
Read More...

Aradigm Corporation asserted that it received a Complete Response Letter from the US Food and Drug Administration regarding its New Drug Application (NDA) for Linhaliq for treating …
Read More...

TFS International and Arclon Biotech decided to continue their partnership with TFS advancing their Alzheimer's disease vaccine ABvac40 into phase II. AD is a progressive disease…
Read More...

For routine prophylaxis of bleeding episodes in people with hemophilia A with factor VIII inhibitors, Chugai Pharmaceuticals sought positive response from EU Committee for Medicinal…
Read More...

Alligator Biosciences affirmed the appointment of Theradex Oncology as CRO for the planned phase I study of ATOR-1015 for the treatment of metastatic cancer anticipated to begin in the…
Read More...

Veracyte asserted that till date its has performed 100,000 Afirma genomic tests to quell unwanted surgeries in patients being assessed for potential thyroid cancer. The announcement…
Read More...